Bogomolets National Medical University

OrganisationROR

Trials

  • NCT03211871

    Phase 3, Status unknown, 60 people, 7 Jul 2017

  • NCT02496650

    Phase 4, Completed, 70 people, 14 Jul 2015

Grants and prizes

  • European Commission

    HORIZON-RIA, SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE), 101156555, €58.2k, 2025–2032, 10 Dec 2024

Sources: cordis.europa.eu